Trial Profile
A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Jun 2020
Price :
$35
*
At a glance
- Drugs Valbenazine (Primary)
- Indications Drug-induced dyskinesia
- Focus Adverse reactions
- Sponsors Neurocrine Biosciences
- 15 Jul 2019 Status changed from recruiting to completed.
- 17 Oct 2018 New trial record